Precision Molecular Pathology of Aggressive B-Cell Lymphomas
162,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
  • Gebundenes Buch

Written by experts in the field, Precision Molecular Pathology of Aggressive B-Cell Lymphomas contains the most recent revisions from the 5th Edition WHO and 2022 International Consensus Classification diagnostic categories and serves as an important resource for trainees, pathologists, haematologist/oncologists, other clinicians involved in lymphoma care and lymphoma researchers. It provides a comprehensive yet concise synthesis of emerging molecular advances that inform patient care and improve understanding of disease mechanisms. In addition, it provides the necessary background to how…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Written by experts in the field, Precision Molecular Pathology of Aggressive B-Cell Lymphomas contains the most recent revisions from the 5th Edition WHO and 2022 International Consensus Classification diagnostic categories and serves as an important resource for trainees, pathologists, haematologist/oncologists, other clinicians involved in lymphoma care and lymphoma researchers. It provides a comprehensive yet concise synthesis of emerging molecular advances that inform patient care and improve understanding of disease mechanisms. In addition, it provides the necessary background to how molecular techniques are performed to enable the reader to better interpret and critically evaluate relevant and emerging data.

As part of the Molecular Pathology Library series, this book focuses specifically on aggressive B-cell lymphomas given the increasing relevance of molecular data for diagnosis and treatment of these disorders. This evidence-based text contains 25 chaptersand is divided into 5 parts. Part 1 provides a brief history and background of aggressive B-cell lymphomas. Landmark events in their classification and treatment are given in order to place the substantial advances in the field in context. Part 2 reviews molecular pathology methods, including the increasing use of next generation sequencing techniques in clinical practice. Parts 3 and 4 focus on individual subtypes of aggressive B-cell lymphoma, including a summary of the diagnostic criteria and key pathologic and clinical features for each entity. Finally, Part 5 focuses on emerging molecular technologies that may significantly impact clinical practice.

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Genevieve M. Crane is a hematopathologist at the Cleveland Clinic, also serving as Medical Director of Manual Hematology and Associate Medical Director of the Immunohistochemistry Lab.  She completed her undergraduate work at Rice University in chemical engineering, followed by a Marshall Scholarship at University College London. She pursued MD and PhD degrees at the University of Michigan as part of the Medical Scientist Training Program, where her graduate work in Cell and Molecular Biology was recognized by a Harold Weintraub Award as one of the most outstanding in the country. She completed residency training at Johns Hopkins Hospital in anatomic pathology and a fellowship in hematopathology. She has more than 60 peer-reviewed publications, has authored two prior textbooks, Survival Guide to Lymph Node Pathology (Innovative Science Press, 2021) and Biopsy Interpretation of the Bone Marrow (Wolters Kluwer, 2023), and multiple book chapters. She is invited to speak nationally and internationally based on her expertise. She serves on multiple editorial boards including as a Section Editor for Hematopathology at Archives of Pathology and Laboratory Medicine and Deputy Editor-in-Chief PathologyOutlines.com. She is passionate about pathology education and outreach, including through multiple pathology organizations.  Dr. Sanam Loghavi completed her MD degrees at Azad University of Medical Sciences in Tehran Iran followed by AP/CP residency training at Cedars-Sinai Medical Center in Los Angeles, CA. She completed fellowships in surgical pathology, hematopathology and molecular pathology at MD Anderson Cancer Center in Houston Texas, where she is currently on staff as an Assistant Professor in the Department of Hematopathology and the director of the Leukemia Tissue Bank and Leukemia Translational Research Laboratory at the Department of Translational Molecular Pathology at MDACC. She has more than 80 peer-reviewed publications and multiple book chapters. She serves regularly as a speaker and session chair at national and international pathology meetings with focus on hematopathology and molecular pathology topics. Dr. Loghavi also serves as a member of the International Clinical Cytometry Society Education Committee and as an Editorial Intern for Lab Medicine journal